{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:12:45Z","timestamp":1793419965935,"version":"4.5.0"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neubiorev.2015.04.015","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T12:51:00Z","timestamp":1430916660000},"page":"294-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":425,"special_numbering":"C","title":["Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review"],"prefix":"10.1016","volume":"55","author":[{"family":"Deepmala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna","family":"Delhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Spielholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrn2356","article-title":"Metaplasticity: tuning synapses and networks for plasticity","volume":"9","author":"Abraham","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0074-7742(06)78005-9","article-title":"Alterations of serotonin transmission in schizophrenia","volume":"78","author":"Abi-Dargham","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.npp.1301119","article-title":"Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists","volume":"32","author":"Achat-Mendes","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/JCP.0b013e318272677d","article-title":"N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Afshar","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.cdd.4400678","article-title":"Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro","volume":"7","author":"Allen","year":"2000","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.neubiorev.2015.04.015_bib0035","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","article-title":"Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients","volume":"38","author":"Altuntas","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/npp.2010.226","article-title":"Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans","volume":"36","author":"Amen","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2012.06.014","article-title":"N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice","volume":"691","author":"Amrouche-Mekkioui","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0050","first-page":"263","article-title":"3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder","volume":"34","author":"Andreazza","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: a case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ajmg.b.32086","article-title":"The mitochondrial genome and psychiatric illness","volume":"159b","author":"Anglin","year":"2012","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0065","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1038\/tp.2012.107","article-title":"Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders","volume":"2","author":"Anglin","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.neuropsych.11110345","article-title":"The psychiatric presentation of mitochondrial disorders in adults","volume":"24","author":"Anglin","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/14734220601142878","article-title":"N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology","volume":"6","author":"Arakawa","year":"2007","journal-title":"Cerebellum"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.annemergmed.2004.05.014","article-title":"Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death","volume":"44","author":"Bailey","year":"2004","journal-title":"Ann. Emerg. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0090","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1301532","article-title":"Contribution of cystine\u2013glutamate antiporters to the psychotomimetic effects of phencyclidine","volume":"33","author":"Baker","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine\u2013glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.04.015_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00726-001-0122-6","article-title":"Cystine\/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration","volume":"23","author":"Baker","year":"2002","journal-title":"Amino Acids"},{"issue":"20","key":"10.1016\/j.neubiorev.2015.04.015_bib0105","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0110","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/MPH.0b013e3181d419ad","article-title":"Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia","volume":"32","author":"Baker","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0115","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0120","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1471-4159.2001.00075.x","article-title":"Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function","volume":"76","author":"Barger","year":"2001","journal-title":"J. Neurochem."},{"issue":"1\/2","key":"10.1016\/j.neubiorev.2015.04.015_bib0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.etp.2011.05.002","article-title":"An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats","volume":"65","author":"Basha","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0130","first-page":"13","article-title":"Role of serotonin in obsessive-compulsive disorder","volume":"35","author":"Baumgarten","year":"1997","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pbb.2011.12.018","article-title":"The cystine\u2013glutamate transporter enhancer N-acetyl-l-cysteine attenuates cocaine-induced changes in striatal dopamine but not self-administration in squirrel monkeys","volume":"101","author":"Bauzo","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities","volume":"4","author":"Bavarsad Shahripour","year":"2014","journal-title":"Brain Behav."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0145","doi-asserted-by":"crossref","first-page":"609421","DOI":"10.1155\/2012\/609421","article-title":"Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder","volume":"2012","author":"Behr","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-1211(00)00096-6","article-title":"Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies","volume":"40","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia \u2013 a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder \u2013 a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.04.015_bib0165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1741-7015-10-91","article-title":"Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial","volume":"10","author":"Berk","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0175","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08454","article-title":"The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial","volume":"75","author":"Berk","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"s434","key":"10.1016\/j.neubiorev.2015.04.015_bib0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","volume":"116","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S1092852900023002","article-title":"Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting","volume":"14","author":"Berk","year":"2009","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4088\/JCP.09m05741yel","article-title":"Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia","volume":"72","author":"Berk","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1601-5215.2009.00397.x","article-title":"Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial","volume":"21","author":"Bernardo","year":"2009","journal-title":"Acta Neuropsychiatr."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0210","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.157.4.1630","article-title":"In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation","volume":"157","author":"Blackwell","year":"1996","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaac.2012.12.020","article-title":"N-acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial","volume":"52","author":"Bloch","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4 Pt 2","key":"10.1016\/j.neubiorev.2015.04.015_bib0220","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/15622970903144004","article-title":"Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia","volume":"10","author":"Bulut","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.neubiorev.2015.04.015_bib0225","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.03-0073rev","article-title":"Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis","volume":"17","author":"Cadet","year":"2003","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0230","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","article-title":"Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy","volume":"18","author":"Capuron","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0235","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4530(01)00030-0","article-title":"Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy","volume":"26","author":"Capuron","year":"2001","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0240","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.neubiorev.2015.04.015_bib0245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0166-2236(02)02289-0","article-title":"Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?","volume":"25","author":"Carlezon","year":"2002","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0250","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/JCP.0b013e31829839c6","article-title":"N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression","volume":"33","author":"Carvalho","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0255","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0260","doi-asserted-by":"crossref","first-page":"716458","DOI":"10.1155\/2008\/716458","article-title":"Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine","volume":"2008","author":"Chen","year":"2008","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4000266","article-title":"Evidence of linkage between the serotonin transporter and autistic disorder","volume":"2","author":"Cook","year":"1997","journal-title":"Mol. Psychiatry"},{"issue":"15","key":"10.1016\/j.neubiorev.2015.04.015_bib0270","doi-asserted-by":"crossref","first-page":"Rc89","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","article-title":"Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction","volume":"20","author":"Cornish","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J069v20n03_05","article-title":"Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens","volume":"20","author":"Cornish","year":"2001","journal-title":"J. Addict. Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0280","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.burns.2011.09.011","article-title":"Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn","volume":"38","author":"Csontos","year":"2012","journal-title":"Burns"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0285","doi-asserted-by":"crossref","DOI":"10.1177\/0004867412474074","article-title":"Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo","author":"Das","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","article-title":"Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment","volume":"36","author":"Davidson","year":"2001","journal-title":"Brain Res. Rev."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0295","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1365-2362.2000.00736.x","article-title":"N-acetylcysteine replenishes glutathione in HIV infection","volume":"30","author":"De Rosa","year":"2000","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4684-5302-7_39","article-title":"Attempted treatment of motor neuron disease with N-acetylcysteine and dithiothreitol","volume":"209","author":"De Jong","year":"1987","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0305","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1440-1819.2012.02392.x","article-title":"Effects of N-acetyl cysteine on cognitive function in bipolar disorder","volume":"66","author":"Dean","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0315","first-page":"99","article-title":"The role for N-acetylcysteine in the management of COPD","volume":"1","author":"Dekhuijzen","year":"2006","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"20","key":"10.1016\/j.neubiorev.2015.04.015_bib0320","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1073\/pnas.0307850101","article-title":"Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress","volume":"101","author":"Deng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0325","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0893-133X(01)00235-4","article-title":"Dissociable effects of antagonism of NMDA and AMPA\/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior","volume":"25","author":"Di Ciano","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0330","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev. Neurother."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0340","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0345","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1523\/JNEUROSCI.19-02-00562.1999","article-title":"Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione","volume":"19","author":"Dringen","year":"1999","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0350","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.59.9.1447","article-title":"N-acetylcysteine and Unverricht\u2013Lundborg disease: variable response and possible side effects","volume":"59","author":"Edwards","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0355","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1526-4637.2003.03040.x","article-title":"Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36","volume":"4","author":"Elliott","year":"2003","journal-title":"Pain Med."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0360","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.22-09-03312.2002","article-title":"Psychomotor stimulant addiction: a neural systems perspective","volume":"22","author":"Everitt","year":"2002","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0365","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/WNF.0000000000000001","article-title":"N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"36","author":"Farokhnia","year":"2013","journal-title":"Clin. Neuropharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0370","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1440-1681.1999.03157.x","article-title":"Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats","volume":"26","author":"Flora","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0375","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2004.04.072","article-title":"Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine","volume":"1016","author":"Fukami","year":"2004","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0380","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-5618.2010.00834.x","article-title":"Assessing oxidative pathway genes as risk factors for bipolar disorder","volume":"12","author":"Fullerton","year":"2010","journal-title":"Bipolar Disord."},{"issue":"13","key":"10.1016\/j.neubiorev.2015.04.015_bib0385","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.18-13-04861.1998","article-title":"Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter","volume":"18","author":"Fumagalli","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0390","doi-asserted-by":"crossref","first-page":"428010","DOI":"10.1155\/2012\/428010","article-title":"Mechanism of oxidative stress in neurodegeneration","volume":"2012","author":"Gandhi","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0395","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","article-title":"Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus","volume":"65","author":"Garcia","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0400","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2249.1993.tb05924.x","article-title":"Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality","volume":"91","author":"Gatti","year":"1993","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0405","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0410","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2009.08.025","article-title":"N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus","volume":"79","author":"Geiler","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0415","first-page":"985","article-title":"N-acetylcysteine for treatment of autism, a case report","volume":"17","author":"Ghanizadeh","year":"2012","journal-title":"J. Res. Med. Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0420","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1871523011312030003","article-title":"N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial","volume":"12","author":"Ghanizadeh","year":"2013","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0425","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-244X-13-196","article-title":"A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders","volume":"13","author":"Ghanizadeh","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3940(91)90045-U","article-title":"Oxidized glutathione modulates N-methyl-d-aspartate- and depolarization-induced increases in intracellular Ca2+ in cultured rat forebrain neurons","volume":"133","author":"Gilbert","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0435","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","article-title":"Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex","volume":"159","author":"Goldstein","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0440","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0445","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/appi.ajp.2012.12040508","article-title":"Skin picking disorder","volume":"169","author":"Grant","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0450","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.13m08411","article-title":"A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers","volume":"75","author":"Grant","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0455","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0460","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","article-title":"A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence","volume":"20","author":"Grant","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0465","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents","volume":"169","author":"Gray","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0470","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1521-0391.2009.00027.x","article-title":"N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study","volume":"19","author":"Gray","year":"2010","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0475","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5811\/westjem.2012.4.6885","article-title":"Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and meta-analysis","volume":"14","author":"Green","year":"2013","journal-title":"West. J. Emerg. Med."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0480","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0485","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0490","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/schbul\/sbq031","article-title":"Dopaminergic dysfunction in schizophrenia: salience attribution revisited","volume":"36","author":"Heinz","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0495","doi-asserted-by":"crossref","first-page":"e54163","DOI":"10.1371\/journal.pone.0054163","article-title":"Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study","volume":"8","author":"Hoffer","year":"2013","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2012","journal-title":"Clin. Neuropharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0505","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1046\/j.0953-816x.2001.01804.x","article-title":"Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure","volume":"14","author":"Hotsenpiller","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0510","series-title":"The Oxford 2011 Levels of Evidence","author":"Howick","year":"2011"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0515","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.47.5.1264","article-title":"Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht\u2013Lundborg type with N-acetylcysteine","volume":"47","author":"Hurd","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0520","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","article-title":"Neural mechanisms of addiction: the role of reward-related learning and memory","volume":"29","author":"Hyman","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0525","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0530","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141b","author":"James","year":"2006","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatr. Genet."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0535","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s10803-008-0591-5","article-title":"Abnormal transmethylation\/transsulfuration metabolism and DNA hypomethylation among parents of children with autism","volume":"38","author":"James","year":"2008","journal-title":"J. Autism Dev. Disord."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0540","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism","volume":"23","author":"James","year":"2009","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0545","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1203\/01.pdr.0000215045.91122.44","article-title":"Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats","volume":"59","author":"Jatana","year":"2006","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0550","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10","article-title":"A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders","volume":"13","author":"Jobe","year":"1998","journal-title":"Crit. Rev. Neurobiol."},{"issue":"22","key":"10.1016\/j.neubiorev.2015.04.015_bib0555","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.1523\/JNEUROSCI.19-22-09780.1999","article-title":"Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area","volume":"19","author":"Jones","year":"1999","journal-title":"J. Neurosci."},{"issue":"3\u20134","key":"10.1016\/j.neubiorev.2015.04.015_bib0560","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","article-title":"N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?","volume":"83","author":"Kantrowitz","year":"2010","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0565","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3371\/CSRP.4.3.6","article-title":"Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models","volume":"4","author":"Kantrowitz","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychos."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0570","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroscience.2008.06.010","article-title":"Blunted cystine\u2013glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking","volume":"155","author":"Kau","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0575","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.neuropsych.12050109","article-title":"The dynamic brain: neuroplasticity and mental health","volume":"24","author":"Kays","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0580","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jnr.20087","article-title":"Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke","volume":"76","author":"Khan","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0585","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2011.10.025","article-title":"System x(c)(\u2212) regulates microglia and macrophage glutamate excitotoxicity in vivo","volume":"233","author":"Kigerl","year":"2012","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0590","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","article-title":"The role of cystine\u2013glutamate exchange in nicotine dependence in rats and humans","volume":"65","author":"Knackstedt","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0595","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archpsyc.61.3.300","article-title":"Molecular evidence for mitochondrial dysfunction in bipolar disorder","volume":"61","author":"Konradi","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2015.01.002","article-title":"Efficacy and safety of N-acetylcysteine in prevention of noise induced hearing loss: a randomized clinical trial","author":"Kopke","year":"2015","journal-title":"Hear. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-1136(199801)22:1<11::AID-GLIA2>3.0.CO;2-B","article-title":"Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine","volume":"22","author":"Kranich","year":"1998","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0610","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia","volume":"32","author":"Kunz","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2015.04.015_bib0615","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.biopsych.2011.10.024","article-title":"The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine","volume":"71","author":"Kupchik","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0620","first-page":"281","article-title":"Therapeutic trial with N-acetylcysteine in amyotrophic lateral sclerosis","volume":"209","author":"K\u00fcther","year":"1987","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0625","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0630","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1521-0391.2013.12034.x","article-title":"A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence","volume":"22","author":"LaRowe","year":"2013","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0635","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"Am. J. Addict."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0640","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.2007.164.7.1115","article-title":"Is cocaine desire reduced by N-acetylcysteine?","volume":"164","author":"LaRowe","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0645","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2014.02.006","article-title":"N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies","volume":"81","author":"Lee","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0650","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/07853899809002489","article-title":"Clinical features and genetics of progressive myoclonus epilepsy of the Unverricht\u2013Lundborg type","volume":"30","author":"Lehesjoki","year":"1998","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0655","first-page":"308","article-title":"Stimulation of N-methyl-d-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione","volume":"41","author":"Leslie","year":"1992","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0660","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0665","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.mito.2004.07.021","article-title":"Mitochondrial damage and dysfunction in traumatic brain injury","volume":"4","author":"Lifshitz","year":"2004","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0670","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00520-006-0018-9","article-title":"N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data","volume":"14","author":"Lin","year":"2006","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0675","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2261-14-52","article-title":"Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: a meta-analysis of published randomized controlled trials","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0680","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneur.1995.00540300031009","article-title":"Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis","volume":"52","author":"Louwerse","year":"1995","journal-title":"Arch. Neurol."},{"issue":"51","key":"10.1016\/j.neubiorev.2015.04.015_bib0685","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1523\/JNEUROSCI.2808-07.2007","article-title":"Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine","volume":"27","author":"Madayag","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0690","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.04.015_bib0695","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2010.08.001","article-title":"N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial","volume":"129","author":"Magalhaes","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0700","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","article-title":"N-acetylcysteine for major depressive episodes in bipolar disorder","volume":"33","author":"Magalhaes","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0705","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0004867413481631","article-title":"A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania","volume":"47","author":"Magalhaes","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0710","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pnpbp.2011.11.011","article-title":"Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder","volume":"37","author":"Magalhaes","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0715","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1399-6576.2011.02492.x","article-title":"Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial","volume":"55","author":"Mahmoud","year":"2011","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"s433","key":"10.1016\/j.neubiorev.2015.04.015_bib0720","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0447.2007.00969.x","article-title":"Does dopamine dysfunction drive depression?","volume":"115","author":"Malhi","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0725","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2015.04.015_bib0730","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","article-title":"The role of oxidative stress in Alzheimer disease","volume":"56","author":"Markesbery","year":"1999","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0735","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/cap.2013.0137","article-title":"N-acetylcysteine as treatment for self-injurious behavior in a child with autism","volume":"24","author":"Marler","year":"2014","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"22","key":"10.1016\/j.neubiorev.2015.04.015_bib0740","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0745","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0165-6147(02)02060-6","article-title":"Cerebral cystine uptake: a tale of two transporters","volume":"23","author":"McBean","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0750","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/gps.1376","article-title":"Co-administration of N-acetylcysteine, vitamin B12 and folate in cognitively impaired hyperhomocysteinaemic patients","volume":"20","author":"McCaddon","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0755","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/00952990.2013.878718","article-title":"Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents","volume":"40","author":"McClure","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"21","key":"10.1016\/j.neubiorev.2015.04.015_bib0760","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1523\/JNEUROSCI.21-21-08655.2001","article-title":"The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior","volume":"21","author":"McFarland","year":"2001","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0765","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0770","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-011-1260-7","article-title":"Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism","volume":"42","author":"Melnyk","year":"2012","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0775","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ajmg.a.36306","article-title":"An open-label pilot study of N-acetylcysteine for skin-picking in Prader\u2013Willi syndrome","volume":"164A","author":"Miller","year":"2014","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"27","key":"10.1016\/j.neubiorev.2015.04.015_bib0780","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","article-title":"Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking","volume":"25","author":"Moran","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0785","first-page":"28","article-title":"The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study","volume":"18","author":"Mousavi","year":"2015","journal-title":"Arch. Iran. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0790","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nn.2250","article-title":"N-acetylcysteine reverses cocaine-induced metaplasticity","volume":"12","author":"Moussawi","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0795","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0196-0644(97)70153-7","article-title":"Angioedema with oral N-acetylcysteine","volume":"30","author":"Mroz","year":"1997","journal-title":"Ann. Emerg. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0800","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2007.01.001","article-title":"Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors","volume":"81","author":"M\u00fcller","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0805","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/pdi.2009.00073","article-title":"Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study","volume":"30","author":"Nascimento","year":"2010","journal-title":"Perit. Dial. Int."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0810","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNF.0000000000000063","article-title":"N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety","volume":"38","author":"Nikoo","year":"2015","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0815","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.jcp.0000264976.86990.00","article-title":"N-acetyl cysteine in the treatment of grooming disorders","volume":"27","author":"Odlaug","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0820","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14336\/AD.2014.0500256","article-title":"Accelerated aging in schizophrenia patients: the potential role of oxidative stress","volume":"5","author":"Okusaga","year":"2014","journal-title":"Aging Dis."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0825","series-title":"Pediatric & Neonatal Lexi-Drugs Online\u2122","author":"OnlineTM","year":"2011"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0830","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00011-011-0323-8","article-title":"Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages","volume":"60","author":"Palacio","year":"2011","journal-title":"Inflamm. Res."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0835","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI29444","article-title":"S-nitrosothiols signal hypoxia-mimetic vascular pathology","volume":"117","author":"Palmer","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0840","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1523\/JNEUROSCI.22-07-02916.2002","article-title":"Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens","volume":"22","author":"Park","year":"2002","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.04.015_bib0850","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.4049\/jimmunol.152.7.3578","article-title":"Involvement of the cystine transport system xc\u2212 in the macrophage-induced glutamate-dependent cytotoxicity to neurons","volume":"152","author":"Piani","year":"1994","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0855","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1523\/JNEUROSCI.16-04-01550.1996","article-title":"Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization","volume":"16","author":"Pierce","year":"1996","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0860","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/glia.1037","article-title":"Visualising the activity of the cystine\u2013glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate","volume":"34","author":"Pow","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0865","doi-asserted-by":"crossref","DOI":"10.1179\/1351000215Y.0000000004","article-title":"N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study","author":"Prado","year":"2015","journal-title":"Redox Rep."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib0870","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/HCO.0b013e3283653f41","article-title":"Therapeutic strategies to prevent contrast-induced acute kidney injury","volume":"28","author":"Quintavalle","year":"2013","journal-title":"Curr. Opin. Cardiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0875","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152707780619326","article-title":"Gliogenesis and glial pathology in depression","volume":"6","author":"Rajkowska","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0880","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.111.179317","article-title":"Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking","volume":"337","author":"Reichel","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0885","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","article-title":"Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","volume":"24","author":"Remington","year":"2009","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0890","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J. Club"},{"issue":"10","key":"10.1016\/j.neubiorev.2015.04.015_bib0895","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/mp.2013.67","article-title":"Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients","volume":"18","author":"Robicsek","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0900","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0974-7753.100090","article-title":"N-acetylcysteine in the treatment of trichotillomania","volume":"4","author":"Rodrigues-Barata","year":"2012","journal-title":"Int. J. Trichol."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0905","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1038\/tp.2012.61","article-title":"Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0910","first-page":"986519","article-title":"Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism","volume":"2012","author":"Rose","year":"2012","journal-title":"Autism Res. Treat."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0915","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0920","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.addbeh.2012.11.003","article-title":"Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial","volume":"38","author":"Roten","year":"2013","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib0925","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0930","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib0935","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","article-title":"N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease","volume":"9","author":"Sandhir","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.04.015_bib0940","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/MN:24:1-3:107","article-title":"Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death","volume":"24","author":"Sattler","year":"2001","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0945","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000327682","article-title":"Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study","volume":"17","author":"Schmaal","year":"2011","journal-title":"Eur. Addict. Res."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0950","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2012.66","article-title":"N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study","volume":"37","author":"Schmaal","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"10.1016\/j.neubiorev.2015.04.015_bib0955","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1046\/j.1432-1327.2000.01595.x","article-title":"Glutathione, oxidative stress and neurodegeneration","volume":"267","author":"Schulz","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0960","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.alcohol.2009.09.028","article-title":"Alcoholism and alcohol abstinence: N-acetylcysteine to improve energy expenditure, myocardial oxidative stress, and energy metabolism in alcoholic heart disease","volume":"43","author":"Seiva","year":"2009","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib0965","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.158.8.1206","article-title":"Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET","volume":"158","author":"Sekine","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib0970","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1176\/appi.ajp.160.9.1699","article-title":"Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms","volume":"160","author":"Sekine","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0975","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pnpbp.2007.10.002","article-title":"Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status","volume":"32","author":"Selek","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib0980","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.52.2.426","article-title":"N-acetylcysteine therapy for Unverricht\u2013Lundborg disease","volume":"52","author":"Selwa","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib0985","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate\u2013dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib0990","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/07853890801923753","article-title":"Mitochondrial involvement in psychiatric disorders","volume":"40","author":"Shao","year":"2008","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib0995","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/1516-4446-2013-1154","article-title":"N-acetylcysteine in the treatment of skin-picking disorder","volume":"36","author":"Silva-Netto","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib1005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pnpbp.2012.06.018","article-title":"N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats","volume":"39","author":"Smaga","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib1010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/cap.2012.0066","article-title":"Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety","volume":"22","author":"Strawn","year":"2012","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.04.015_bib1015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/neu.2006.0242","article-title":"Temporal characterization of mitochondrial bioenergetics after spinal cord injury","volume":"24","author":"Sullivan","year":"2007","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib1020","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.13080","article-title":"N-acetylcysteine in trichotillomania \u2013 a panacea for compulsive skin disorders?","author":"Taylor","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib1025","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/10715762.2013.819974","article-title":"N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549)","volume":"47","author":"Tobwala","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib1030","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12240","article-title":"Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission","author":"Tsai","year":"2014","journal-title":"Bipolar Disord."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib1035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1023\/A:1027377605054","article-title":"Glutathione is an endogenous ligand of rat brain N-methyl-d-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors","volume":"22","author":"Varga","year":"1997","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib1040","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1089\/ars.2010.3830","article-title":"The cystine\/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets","volume":"15","author":"Vene","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.04.015_bib1045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/1071576031000148727","article-title":"N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells","volume":"37","author":"Victor","year":"2003","journal-title":"Free Radic. Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2015.04.015_bib1050","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","article-title":"Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"23","key":"10.1016\/j.neubiorev.2015.04.015_bib1055","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib1060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.04.015_bib1065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(96)00071-8","article-title":"Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants","volume":"139","author":"Vyth","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.04.015_bib1070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.euroneuro.2005.07.002","article-title":"Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine","volume":"16","author":"Wan","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib1075","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1046\/j.1471-4159.2000.0741434.x","article-title":"Astrocytes provide cysteine to neurons by releasing glutathione","volume":"74","author":"Wang","year":"2000","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.04.015_bib1080","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.04.015_bib1085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0025-6196(12)61175-6","article-title":"Motor neuron disease (amyotrophic lateral sclerosis)","volume":"66","author":"Williams","year":"1991","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.04.015_bib1090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12035-012-8278-5","article-title":"Role of dopamine receptors in ADHD: a systematic meta-analysis","volume":"45","author":"Wu","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2015.04.015_bib1095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","article-title":"Free radicals, antioxidant defense systems, and schizophrenia","volume":"46","author":"Wu","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.04.015_bib1100","doi-asserted-by":"crossref","first-page":"R1263","DOI":"10.1152\/ajpregu.00278.2002","article-title":"Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice","volume":"283","author":"Yang","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.04.015_bib1105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.annemergmed.2009.05.010","article-title":"Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning","volume":"54","author":"Yarema","year":"2009","journal-title":"Ann. Emerg. Med."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:26:30Z","timestamp":1691627190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763415001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":219,"alternative-id":["S0149763415001190"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2015.04.015","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2015.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}